William McKee is Director at Assertio Therapeutics, Inc (ASRT). They have made 7 open-market trades across 4 companies since 2006, most recently 2026-05-05.
CIK 0001237262
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $100K since 2020, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ASRT | SELL · 10b5-1 | 2023-08-14 | 2023-08-15 | $3.14 | $69K | +4.1% | -12.0% | -67.1% |
| ASRT | SELL | 2022-05-12 | 2022-05-16 | $2.35 | $105K | +12.0% | +2.2% | +34.1% |
| CCCC | BUY | 2020-10-06 | 2020-10-06 | $19.00 | $100K | -8.1% | -5.5% | +16.9% |
| ASRT | SELL | 2019-05-09 | 2019-05-09 | $4.70 | $59K | -27.8% | -34.8% | -43.9% |
| ASRT | SELL · 10b5-1 | 2018-12-14 | 2018-12-17 | $4.07 | $41K | -9.6% | +6.3% | +7.3% |
| AUXL | SELL | 2014-12-05 | 2014-12-08 | $34.00 | $612K | N/A | N/A | N/A |
| AUXL | SELL | 2013-05-20 | 2013-05-22 | $15.10 | $30K | N/A | N/A | N/A |
| BRL | SELL | 2006-02-09 | 2006-02-13 | $68.63 | $3.1M | N/A | N/A | N/A |
| BRL | SELL | 2006-01-03 | 2006-01-04 | $61.85 | $1.6M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.